SCHEMBL18962609

SCHEMBL18962609

N=C/C(=C\N)c1ccc(Cl)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.45
▸ CES2 O00748 2/20 0.39
▸ CES1 P23141 2/20 0.39
▸ TSHR P16473 2/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ CA1 P00915 2/20 0.37
▸ CA2 P00918 2/20 0.37
▸ HTR3E A5X5Y0 1/20 0.35
▸ SLC22A2 O15244 1/20 0.35
▸ SLC22A1 O15245 1/20 0.35
▸ SLC22A3 O75751 1/20 0.35
▸ HTR3B O95264 1/20 0.35
▸ PLAU P00749 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24697541 0.82 PRKACA (0.44) LMNATSHRL3MBTL1MAPK1CYP3A4
SCHEMBL24213539 0.80 PLAU (0.44) LMNATSHRMAPK1ALOX15CYP3A4
SCHEMBL24426657 0.79 DRD2 (0.45) LMNACYP3A4CYP2C19GSK3B
SCHEMBL16923685 0.78 TPMT (0.38) CA1CA2SLC22A2SLC22A1SLC22A3
SCHEMBL14538523 0.78 ALDH1A1 (0.40) LMNACES2CES1ATMALDH1A1
SCHEMBL20644765 0.78 CES2 (0.39) LMNACES2CES1MAPK1ALOX15
SCHEMBL24196737 0.78 IRAK4 (0.30) —
SCHEMBL24690353 0.78 HTT (0.47) LMNAMAPK1KDM4EALDH1A1
SCHEMBL15850351 0.77 F2 (0.42) CES2CES1TSHRL3MBTL1MAPK1
SCHEMBL18962611 0.76 PARP1 (0.48) TSHRKDM4EALDH1A1MAPTHTR3E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017097215-A1 WNT PATHWAY INHIBITOR EMBEDDED WITH UREAS STRUCTURE 杭州雷索药业有限公司 2017-06-15 — — WO disclosed
Send feedback